FGF5 and Parkinson disease: Although we found significantly different levels of our identified markers between controls and each of the PSP, CBS and MSA groups, we found that the APS versus PD signals for FGF-5, FGF-19 and DNER were primarily being driven by lower levels in the MSA group.